Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea
A division bench of the Delhi High Court on Thursday allowed Natco Pharma to launch the drug risdiplam in India, even as it rejected Swiss multinational F. Hoffmann-La Roche AG’s plea seeking to the contrary. The bench led by Justice Hari Shankar vacated its March order that had asked Hyderabad-based Natco Pharma to maintain status…